As of 2025-07-02, the Relative Valuation of Travere Therapeutics Inc (TVTX) is (50.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.80 USD, the upside of Travere Therapeutics Inc based on Relative Valuation is -442.4%.
The range of the Relative Valuation is (42.28) - (60.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 24.2x | 22.5x |
| Forward P/E multiples | 14.7x - 23.8x | 17.2x |
| Fair Price | (42.28) - (60.76) | (50.68) |
| Upside | -385.7% - -510.6% | -442.4% |
| Date | P/E |
| 2025-06-27 | -5.79 |
| 2025-06-26 | -5.93 |
| 2025-06-25 | -5.85 |
| 2025-06-24 | -5.97 |
| 2025-06-23 | -5.68 |
| 2025-06-20 | -5.61 |
| 2025-06-18 | -5.64 |
| 2025-06-17 | -5.52 |
| 2025-06-16 | -5.75 |
| 2025-06-13 | -5.68 |
| 2025-06-12 | -5.85 |
| 2025-06-11 | -5.69 |
| 2025-06-10 | -5.93 |
| 2025-06-09 | -5.84 |
| 2025-06-06 | -6.00 |
| 2025-06-05 | -5.77 |
| 2025-06-04 | -5.96 |
| 2025-06-03 | -6.03 |
| 2025-06-02 | -6.08 |
| 2025-05-30 | -5.88 |
| 2025-05-29 | -6.02 |
| 2025-05-28 | -5.86 |
| 2025-05-27 | -6.01 |
| 2025-05-23 | -6.20 |
| 2025-05-22 | -6.15 |
| 2025-05-21 | -6.50 |
| 2025-05-20 | -6.88 |
| 2025-05-19 | -6.66 |
| 2025-05-16 | -6.58 |
| 2025-05-15 | -8.28 |
| 2025-05-14 | -8.26 |
| 2025-05-13 | -8.20 |
| 2025-05-12 | -8.44 |
| 2025-05-09 | -7.84 |
| 2025-05-08 | -8.01 |
| 2025-05-07 | -7.92 |
| 2025-05-06 | -7.81 |
| 2025-05-05 | -8.39 |
| 2025-05-02 | -8.28 |
| 2025-05-01 | -8.13 |
| 2025-04-30 | -8.15 |
| 2025-04-29 | -7.87 |
| 2025-04-28 | -7.58 |
| 2025-04-25 | -7.18 |
| 2025-04-24 | -6.91 |
| 2025-04-23 | -6.54 |
| 2025-04-22 | -6.22 |
| 2025-04-21 | -5.92 |
| 2025-04-17 | -5.84 |
| 2025-04-16 | -5.71 |